Parkman Healthcare Partners »

Peregrine Pharmaceuticals shares owned by Parkman Healthcare Partners

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Parkman Healthcare Partners from 13F filings

Historical chart of Parkman Healthcare Partners investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Parkman Healthcare Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.8M 186k 9.44
2023-06-30 $2.5M 178k 13.97
2023-03-31 $8.5M 454k 18.76
2022-12-31 $5.9M 428k 13.77
2022-09-30 $7.7M 405k 19.12
2022-06-30 $7.0M 461k 15.26
2022-03-31 $8.3M 408k 20.37
2021-12-31 $8.5M 290k 29.18
2021-09-30 $9.7M 450k 21.57
2021-06-30 $12M 475k 25.65
2021-03-31 $12M 675k 18.23
2020-12-31 $8.6M 750k 11.54
2020-09-30 $3.7M 484k 7.62
2020-06-30 $821k 125k 6.57
2019-12-31 $1.1M 141k 7.67